SCHEMBL9631723

SCHEMBL9631723

Cc1cc(C(=O)CBr)cc(C(C)(C)C)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ALOX5 P09917 2/20 0.47
PTGS1 P23219 2/20 0.47
PTGS2 P35354 2/20 0.47
LMNA P02545 1/20 0.45
RECQL P46063 1/20 0.45
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
GSK3B P49841 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
CA2 P00918 2/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1189097 0.90 ALOX5 (0.55) CYP1A2ALOX5PTGS1PTGS2LMNA
SCHEMBL9862861 0.84 GSK3B (0.52) KMT2AMEN1GSK3BALDH1A1MAPT
SCHEMBL12187574 0.83 ALOX5 (0.47) ALOX5PTGS1PTGS2LMNARECQL
SCHEMBL9178091 0.83 PTGS2 (0.61) CYP1A2CYP2C9CYP2C19ALOX5PTGS1
SCHEMBL9178540 0.82 PTGS2 (0.60) CYP1A2CYP2C9CYP2C19ALOX5PTGS1
SCHEMBL27532704 0.82 ALOX5 (0.46) CYP2C9CYP2C19ALOX5PTGS1PTGS2
SCHEMBL9911749 0.79 CYP1A2 (0.57) CYP1A2CYP2C9CYP2C19ALOX5PTGS1
SCHEMBL30924512 0.79 CYP1A2 (0.57) CYP1A2CYP2C9CYP2C19ALOX5PTGS1
SCHEMBL3807174 0.79 CYP1A2 (0.57) CYP1A2CYP2C9CYP2C19ALOX5PTGS1
SCHEMBL10268453 0.78 ALOX5 (0.43) ALOX5PTGS1PTGS2LMNARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5137897-A Nonsteroidal antiinflammatory agents; therapy for rheumatic diseases HOECHST AKTIENGESLLSCHAFT (DE) 1992-08-11 US disclosed
EP-0432740-A2 2-Substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, process for their preparation, medicaments containing them and their utilization HOECHST AKTIENGESELLSCHAFT (DE) 1991-06-19 EP disclosed
US-4940790-A ANTIINFLAMMATORY AGENTS FOR RHEUMATIC DIORDERS AND PAIN HOECHST AKTIENGESELLSCHAFT (DE) 1990-07-10 US disclosed
US-4908364-A Pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1990-03-13 US disclosed
US-4891374-A INFLAMMATORY RHEUMATIC DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-02 US disclosed